We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.63%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$921M
AUM Growth
-$85.5M
Cap. Flow
-$110M
Cap. Flow %
-11.98%
Top 10 Hldgs %
14.09%
Holding
5,143
New
1,384
Increased
1,284
Reduced
1,171
Closed
1,233

Sector Composition

Rank Sector Weight
1 Financials 13.75%
2 Technology 8.29%
3 Industrials 7.33%
4 Healthcare 6.94%
5 Consumer Discretionary 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KLDX
3726
DELISTED
KLONDEX MINES LTD
KLDX
$1K ﹤0.01%
100
-1,500
-94% -$7.44K
JASO
3727
DELISTED
JA Solar Holdings, Co., Ltd
JASO
$1K ﹤0.01%
+151
New +$854
ADRE
3728
DELISTED
Invesco BLDRS Emerging Markets 50 ADR Index Fund
ADRE
$1K ﹤0.01%
16
-5
-24% -$169
DBBR
3729
DELISTED
Xtrackers MSCI Brazil Hedged Equity ETF
DBBR
$1K ﹤0.01%
64
-18
-22% -$195
FSNN
3730
DELISTED
Fusion Connect, Inc. Common Stock
FSNN
$1K ﹤0.01%
231
-664
-74% -$1.42K
BUFF
3731
DELISTED
Blue Buffalo Pet Products, Inc
BUFF
$1K ﹤0.01%
+24
New +$581
CO
3732
DELISTED
Global Cord Blood Corporation
CO
$1K ﹤0.01%
196
-4,330
-96% -$21.6K
IOIL
3733
DELISTED
IQ Global Oil Small Cap ETF
IOIL
$1K ﹤0.01%
+54
New +$638
GLBL
3734
DELISTED
TerraForm Global, Inc. Class A Common Stock
GLBL
$1K ﹤0.01%
+200
New +$772
OCRX
3735
DELISTED
Ocera Therapeutics, Inc.
OCRX
$1K ﹤0.01%
700
+300
+75% +$700
BSTG
3736
DELISTED
Biostage, Inc. Common Stock
BSTG
$1K ﹤0.01%
645
-9,528
-94% -$8.49K
ALR
3737
DELISTED
Alere Inc
ALR
$1K ﹤0.01%
33
-393
-92% -$15.9K
VTTI
3738
DELISTED
VTTI Energy Partners LP
VTTI
$1K ﹤0.01%
80
-926
-92% -$16.2K
XRA
3739
DELISTED
Exeter Resources Corporation
XRA
$1K ﹤0.01%
1,100
+700
+175% +$670
MSLI
3740
DELISTED
Merus Labs International Inc.
MSLI
$1K ﹤0.01%
1,000
-4,100
-80% -$3.77K
MPSX
3741
DELISTED
Multi Packaging Solutions Intl.
MPSX
$1K ﹤0.01%
100
-176
-64% -$2.44K
WINT
3742
DELISTED
Windtree Therapeutics Inc
WINT
$1K ﹤0.01%
664
+244
+58% +$451
CSC
3743
DELISTED
Computer Sciences
CSC
$1K ﹤0.01%
10
-10,846
-100% -$627K
HNR
3744
DELISTED
Harvest Natural Resources
HNR
$1K ﹤0.01%
+240
New +$1.12K
DRWI
3745
DELISTED
DragonWave Inc
DRWI
$1K ﹤0.01%
400
-700
-64% -$2.08K
CPAH
3746
DELISTED
Counterpath Corp
CPAH
$1K ﹤0.01%
600
-300
-33% -$620
CYTR
3747
DELISTED
CytRx Corp
CYTR
$1K ﹤0.01%
526
+200
+61% +$588
HYGS
3748
DELISTED
Hydrogenics Corp
HYGS
$1K ﹤0.01%
290
-110
-28% -$574
KIQ
3749
DELISTED
Kelso Technologies Inc.
KIQ
$1K ﹤0.01%
800
+600
+300% +$518
GFN
3750
DELISTED
General Finance Corporation
GFN
$1K ﹤0.01%
264
-95
-26% -$427

Similar funds

Tower Research Capital (TRC)'s Q4 2016 Portfolio in Review

As of Q4 2016, Tower Research Capital (TRC) held 5,143 positions worth $921M, down 8.5% from $1.01B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) withdrew a net $110M in Q4 2016, closing 1,233 positions and reducing 1,171 holdings. Its most notable exit was Vanguard Real Estate ETF, an estimated $18.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 3.3% a quarter earlier, followed by Technology and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Biotechnology ETF worth $9.93M.

  • Tower Research Capital (TRC)'s largest Q4 2016 buy was iShares Biotechnology ETF: 112,296 shares worth $9.93M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2016, an estimated $11.2M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $265M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q4 2016, selling an estimated $18.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $921M portfolio in Q4 2016.
  • Tower Research Capital (TRC) opened 1,384 new positions and closed 1,233 in Q4 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 8.5% quarter-over-quarter to $921M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.